This content is in French.
Immune checkpoint inhibitor chemotherapy in non-small cell lung cancer
20 mars 2024
While the combination of an immune checkpoint inhibitor and chemotherapy has become a standard treatment for non-small cell lung cancer, there are few data on its value in subjects over 75. In this…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Yoko Tsukita et al. Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer. JAMA Oncol. 2024 Mar 7:e236277.
View the source
